Phenotypic Plasticity and Cancer: A System Biology Perspective
Authors:
- Ayalur Raghu SubbalakshmiASAyalur Raghu Subbalakshmi
- Sravani RamisettySRSravani Ramisetty
- Atish MohantyAMAtish Mohanty
- Siddhika PareekSPSiddhika Pareek
- Dana DoDDDana Do
- Sagun ShresthaSSSagun Shrestha
- Ajaz KhanAKAjaz Khan
- Neel TalwarNTNeel Talwar
- Tingting TanTTTingting Tan
- Priya VishnubhotlaPVPriya Vishnubhotla
- Sharad S. SinghalSSSharad S. Singhal
- Ravi SalgiaRavi Salgia
Open Access
- 23 July 2024
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (15) , 4302
Abstract
Epithelial-to-mesenchymal transition (EMT) is a major axis of phenotypic plasticity not only in diseased conditions such as cancer metastasis and fibrosis but also during normal development and wound healing. Yet-another important axis of plasticity with metastatic implications includes the cancer stem cell (CSCs) and non-CSC transitions. However, in both processes, epithelial (E) and mesenchymal (M) phenotypes are not merely binary states. Cancer cells acquire a spectrum of phenotypes with traits, properties, and markers of both E and M phenotypes, giving rise to intermediary hybrid (E/M) phenotypes. E/M cells play an important role in tumor initiation, metastasis, and disease progression in multiple cancers. Furthermore, the hybrid phenotypes also play a major role in causing therapeutic resistance in cancer. Here, we discuss how a systems biology perspective on the problem, which is implicit in the ‘Team Medicine’ approach outlined in the theme of this Special Issue of The Journal of Clinical Medicine and includes an interdisciplinary team of experts, is more likely to shed new light on EMT in cancer and help us to identify novel therapeutics and strategies to target phenotypic plasticity in cancer.Keywords
Funding Information
- National Cancer Institute of the National Institutes of Health (P30CA33572, W81XWH-22-1-0331, HT9425-23-1-0581)
- United States Department of Defense (P30CA33572, W81XWH-22-1-0331, HT9425-23-1-0581)
This publication has 90 references indexed in Scilit:
- Understanding and targeting resistance mechanisms in cancerMedcomm, 2023
- Hybrid epithelial/mesenchymal phenotype(s): The ‘fittest’ for metastasis?Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2018
- Epithelial/mesenchymal plasticity: how have quantitative mathematical models helped improve our understanding?Molecular Oncology, 2017
- Tumor Metastasis: Molecular Insights and Evolving ParadigmsCell, 2011
- Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer CellsCell, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor ProgressionJournal of Mammary Gland Biology and Neoplasia, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- Cancer Metastasis: Building a FrameworkCell, 2006